NCT03404518

Brief Summary

Patient's pain level and narcotic requirements will be evaluated after routine outpatient Otolaryngology procedures. This will be done by having study participants record their pain level and medication usage from home.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Feb 2018

Shorter than P25 for phase_3

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 19, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

February 21, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

March 16, 2022

Completed
Last Updated

March 16, 2022

Status Verified

February 1, 2022

Enrollment Period

7 months

First QC Date

January 11, 2018

Results QC Date

July 13, 2021

Last Update Submit

February 18, 2022

Conditions

Keywords

ThyroidectomyParotidectomyTympanoplastyMastoidectomySeptoplastySinus SurgeryPostoperative painOutpatient surgery

Outcome Measures

Primary Outcomes (1)

  • Narcotic Usage

    The average number of narcotic pills needed or used for pain control

    First 7 days after surgery

Secondary Outcomes (2)

  • Patient Pain Level

    Average reported pain for first 7 days after surgery

  • Ibuprofen Usage

    First 7 days after surgery

Study Arms (2)

Norco and Ibuprofen

EXPERIMENTAL

This group will take Hydrocodone/acetaminophen 5mg/325mg every 6 hours as needed for pain control as first line intervention. If pain is not controlled after 60 minutes then can take Ibuprofen 600mg every 6 hours as needed for additional pain control.

Drug: Norco

Ibuprofen and Norco

ACTIVE COMPARATOR

This group will take Ibuprofen 600mg every 6 hours as needed for pain control as first line intervention. If pain is not controlled after 60 minutes then can take Hydrocodone/acetaminophen 5mg/325mg every 6 hours as needed for additional pain control.

Drug: Ibuprofen

Interventions

NorcoDRUG

Hydrocodone/Acetaminophen as first line therapy every 6 hours as needed for pain control

Also known as: Hydrocodone/Acetaminophen, Narcotic
Norco and Ibuprofen

Ibuprofen as first line therapy every 6 hours as needed for pain control

Also known as: NSAID, Motrin, Advil
Ibuprofen and Norco

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing one of the following outpatient procedure:
  • Septoplasty
  • Unilateral or Bilateral Functional endoscopic sinus surgery
  • Tympanomastoidectomy
  • Tympanoplasty
  • Total or Partial Thyroidectomy
  • Parathyroidectomy
  • Parotidectomy.
  • Age \>18 years and \< 89 years

You may not qualify if:

  • Age \< 18 years or \> 89 years
  • Post operative hospital admission
  • Allergy to Hydrocodone
  • Allergy or contraindication to Ibuprofen or NSAIDs
  • Pregnancy
  • Hepatic disease
  • Chronic kidney disease
  • Sickle cell anemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Loma Linda University Medical Center

Loma Linda, California, 92354, United States

Location

Loma Linda University Surgical Hospital

Loma Linda, California, 92354, United States

Location

Related Publications (7)

  • Sommer M, Geurts JW, Stessel B, Kessels AG, Peters ML, Patijn J, van Kleef M, Kremer B, Marcus MA. Prevalence and predictors of postoperative pain after ear, nose, and throat surgery. Arch Otolaryngol Head Neck Surg. 2009 Feb;135(2):124-30. doi: 10.1001/archoto.2009.3.

    PMID: 19221238BACKGROUND
  • Foghsgaard S, Foghsgaard J, Homoe P. Early post-operative morbidity after superficial parotidectomy: a prospective study concerning pain and resumption of normal activity. Clin Otolaryngol. 2007 Feb;32(1):54-7. doi: 10.1111/j.1365-2273.2007.01315.x.

    PMID: 17298314BACKGROUND
  • Song CM, Ji YB, Bang HS, Kim KR, Kim H, Tae K. Postoperative Pain After Robotic Thyroidectomy by a Gasless Unilateral Axillo-Breast or Axillary Approach. Surg Laparosc Endosc Percutan Tech. 2015 Dec;25(6):478-82. doi: 10.1097/SLE.0000000000000204.

    PMID: 26422088BACKGROUND
  • van Dijk JF, Kappen TH, Schuurmans MJ, van Wijck AJ. The Relation Between Patients' NRS Pain Scores and Their Desire for Additional Opioids after Surgery. Pain Pract. 2015 Sep;15(7):604-9. doi: 10.1111/papr.12217. Epub 2014 Apr 16.

    PMID: 24735082BACKGROUND
  • van Dijk JF, van Wijck AJ, Kappen TH, Peelen LM, Kalkman CJ, Schuurmans MJ. Postoperative pain assessment based on numeric ratings is not the same for patients and professionals: a cross-sectional study. Int J Nurs Stud. 2012 Jan;49(1):65-71. doi: 10.1016/j.ijnurstu.2011.07.009. Epub 2011 Aug 15.

    PMID: 21840522BACKGROUND
  • Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth. 2011 Oct;107(4):619-26. doi: 10.1093/bja/aer195. Epub 2011 Jun 30.

    PMID: 21724620BACKGROUND
  • Ossiander EM. Using textual cause-of-death data to study drug poisoning deaths. Am J Epidemiol. 2014 Apr 1;179(7):884-94. doi: 10.1093/aje/kwt333. Epub 2014 Feb 11.

    PMID: 24521559BACKGROUND

Related Links

MeSH Terms

Conditions

Pain, Postoperative

Interventions

oxycodone-acetaminophenNarcoticsIbuprofenAnti-Inflammatory Agents, Non-Steroidal

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Central Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnalgesicsSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesPhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAnalgesics, Non-NarcoticAnti-Inflammatory AgentsAntirheumatic Agents

Limitations and Caveats

Some patients chose to not follow study instructions strictly and utilized ibuprofen therapy as primary analgesic treatment instead of their opioid medication.

Results Point of Contact

Title
Khanh Nguyen, MD
Organization
Loma Linda University Health System

Study Officials

  • Jared Inman, MD

    Loma Linda University Health System

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized to one of two groups prior to surgery. All patients will be prescribed both Hydrocodone/acetaminophen and Ibuprofen. Group 1 will take the narcotic medication for initial pain control followed by Ibuprofen if pain is not adequately controlled. Group 2 will take Ibuprofen for initial pain control followed by the narcotic medication if pain is not adequately controlled.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 11, 2018

First Posted

January 19, 2018

Study Start

February 21, 2018

Primary Completion

October 1, 2018

Study Completion

October 1, 2018

Last Updated

March 16, 2022

Results First Posted

March 16, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Collected data will be analyzed and published. Meaningful data will be available through published material.

Locations